Publisher: Adis International
ISSN: 1173-8324
Source: Inpharma, Vol.1, Iss.1564, 2006-01, pp. : 12-12
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Moxifloxacin IV-to-oral switch proves cost effective in patients with CAP
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 368, 2002-01 ,pp. :
Moxifloxacin IV-to-oral switch proves cost effective in patients with CAP
Inpharma, Vol. 1, Iss. 1343, 2002-01 ,pp. :
IV-to-oral antibacterial switch cuts treatment time in CAP
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 523, 2007-01 ,pp. :
Short-course antibacterials beneficial in CAP
Inpharma, Vol. 1, Iss. 1653, 2008-01 ,pp. :
Moxifloxacin, nonstandardised antibacterials equivalent in CAP
Inpharma, Vol. 1, Iss. 1517, 2005-01 ,pp. :